Pharmaceutical companies could serve their own interests by supporting research on the efficacy of psychotherapy on premature ejaculation.
For many men, the treatment of sexual dysfunctions such as premature ejaculation may well be most effective when pharmacotherapy is combined with psychotherapy. Yet the essential elements of psychotherapy that might best be combined with pharmacological-based therapy are currently unknown. Support for evidence-based studies that identify key components of psychotherapy that might improve positive long-term outcomes, including patient satisfaction, are needed. Pharmaceutical companies having a vested interest in achieving both treatment adherence and improved patient outcomes could benefit from such information.
Department of Psychology, Valparaiso University, 1001 Campus Drive South, Valparaiso, IN 46383, USA. david.rowland@valpo.edu
D
D
Rowland
S
S
Cooper
L
L
Macias
D004345:Drug Industry / Q000191:economics*; D004542:Ejaculation; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D011613:Psychotherapy; D012106:Research; D012109:Research Support as Topic; D012735:Sexual Dysfunction, Physiological / Q000628:therapy*; D020018:Sexual Dysfunctions, Psychological / Q000628:therapy*